Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells.

Abstract

The pattern of endogenous estradiol metabolism may play a role in defining ovarian cancer risk. This may be of importance in certain predisposed women who are treated with hormone therapy in postmenopause.